Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Abortion Could Prove Divisive For Health Reform, Too
An ultimatum against using federal money for abortion procedures could reopen the politically treacherous rift over the issue, creating yet another obstacle for congressional Democrats to overcome if they are to achieve their health reform goals, Time reports. "While current versions of the [health reform] legislation do not address the abortion issue at all, late last month 19 anti-abortion Democrats in the House sent a letter to Speaker Nancy Pelosi, warning "we cannot support any health care reform proposal unless it explicitly excludes abortion from the scope of any government-defined or subsidized health insurance plan.""
generic viagra online
N.Y. Health IT Program A National Model
A New York City health information technology project could provide a model for the implementation of stimulus-funded electronic health records in hospitals and doctors offices around the country, reports Government Health IT, a publication of an e-health lobbying group. "The Primary Care Information Project (PCIP), a program started in 2007 by the New York City Department of Health and Mental Hygiene, supports the adoption of health IT among primary care providers who tend to the city"s underserved populations," the report explains.
News of the day
Jazz Pharmaceuticals To Present Data From First Phase III Study Of Sodium Oxybate In Patients With Fibromyalgia
Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced that data from the company"s first Phase III clinical trial of sodium oxybate (JZP-6) for the treatment of fibromyalgia will be presented this week during the Associated Professional Sleep Societies (APSS) 2009 Annual Meeting in Seattle, Washington and also during the European League Against Rheumatism (EULAR) Congress in Copenhagen, Denmark.
Endocrinology

UK Court Of Appeal Rules In Smith & Nephew's Favour

Smith & Nephew"s Advanced Wound Management division (NYSE:SNN) announced that the UK Court of Appeal has ruled as invalid all claims asserted against Smith and Nephew of the patent EP 0 626 720 that is licensed to Kinetic Concepts, Inc. (NYSE: KCI). As a result, the preliminary injunction against Smith & Nephew"s RENASYS(TM)-F NPWT system has been lifted. The Patents Court had ruled on 1 May, 2009 that 7 out of 10 claims asserted were invalid but that the remaining 3 had been infringed by Smith & Nephews RENASYS-F dressing. This decision was appealed and subsequently won by Smith & Nephew with today"s Court ruling. "This favourable ruling for Smith & Nephew clears a major legal hurdle in the UK allowing us to offer our customers the breadth of NPWT products with proven clinical efficacy," said Robin Carlstein, Senior Vice President of Advanced Wound Devices at Smith & Nephew. "Clearly, we are pleased with the UK Court of Appeal"s findings in this matter and look forward to servicing our customers with our RENASYS(TM)-F NPWT products in a very important market for the company." Smith & Nephew


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009